glp-1 infographic 🚨High Yield Alert!!! 🚨 meds are changing the landscape of weight management — but what happens when they intersect with eating disorders? 🧠💊 In episode #504, Adult Eating Disorders in Tirzepatide Explained: The Future of

Research shows that five GLP-1s account for 16% of the overall prescription cost for the Rx Collaborative, the largest pharmacy coalition in the U.S., after estimated rebates and discounts in Q1-Q3 of 2024, a rise from just 1% in 2020

This may make obtaining medications without a Mexican prescription more difficult in the future, reinforcing the value of establishing a relationship with a Mexican physician now

Noom is basing its offering on a quarter dose of semaglutide 0.6mg per injection versus 2.4mg for Wegovy and said the rationale for the dose reduction comes from data gleaned from its members, as well as a couple of investigator-led studies published in The Lancet and New England Journal of Medicine

Some Gaps in the Science Addiction specialist Dr

Since the FDA mandate, 21 CVOT studies are on track to be completed by 2020, first in predominantly high-risk T2DM patients with established CVD (secondary prevention) and later in broader populations with multiple CVD risk factors (primary prevention) (8)